Baird Medical Investment Holdings Limited (BDMD) Return on equity 2022–2025
Baird Medical Investment Holdings Limited (BDMD) return on equity by fiscal year — reported net income divided by year-end shareholders’ equity.
-87.0%FY2025 · since FY2022: 49.6% → -87.0%
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | -87.0% | -118.4 pp |
| FY2024 | 31.4% | +1.9 pp |
| FY2023 | 29.5% | -20.1 pp |
| FY2022 | 49.6% | — |
ROE = reported net income ÷ reported year-end shareholders’ equity for the same fiscal year. Heavy buybacks shrink equity and can push ROE very high (or negative-equity years drop out).
Source: SEC XBRL filings · For reference only · Not investment advice
More BDMD financial trends
BDMD RevenueBDMD Net incomeBDMD Net marginBDMD Gross profitBDMD Gross marginBDMD Operating incomeBDMD Operating marginBDMD Operating cash flowBDMD Free cash flowBDMD Capital expendituresBDMD Stock buybacksBDMD Dividends paidBDMD Total assetsBDMD Total liabilitiesBDMD Shareholders’ equityBDMD overview →